logo

Miragen Therapeutics, Inc. (MGEN)



Trade MGEN now with
  Date
  Headline
1/19/2021 7:09:52 AM MiRagen Therapeutics Announces Company Name Change To Viridian Therapeutics
7/23/2020 4:52:48 PM MiRagen Says FDA Granted Orphan Drug Designation To Cobomarsen For Treatment Of T-cell Lymphoma
6/18/2020 4:36:43 PM MiRagen Appoints Lee Rauch As COO
2/7/2020 9:14:14 AM MiRagen Reports Pricing Of $15.0 Mln Public Offering Of Common Stock And Warrants To Buy Common Stock
7/29/2019 7:18:17 AM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $24 Price Target
5/10/2019 7:20:31 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) FY20 Estimate To -1.79 From -1.83
5/10/2019 7:20:15 AM Wedbush Is Increasing MIRAGEN THERAPEUTICS, INC. (MGEN) Q4 20 Estimate To -0.46 From -0.47
5/10/2019 7:20:02 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) Q3 20 Estimate To -0.45 From -0.46